home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

63.13 +0.33 (+0.53%)

Streaming Delayed Price Updated: 1:13 PM EDT, Apr 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

47 48 Next >

DXCM DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before October 21, 2024

September 29, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

DXCM DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before October 21, 2024

September 29, 2024

NEW YORK, NY - (NewMediaWire) - September 29, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM)...

Via TheNewswire.com

Topics Lawsuit

ROSEN, A LONGSTANDING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

September 27, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orthofix, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm

September 26, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

What the Options Market Tells Us About DexCom ↗

September 26, 2024

Via Benzinga

Is DexCom a Millionaire Maker? ↗

September 25, 2024

It isn't the most likely candidate to make someone a millionaire, but it's theoretically possible.

Via The Motley Fool

Kirby McInerney LLP Notifies Investors of Lead Plaintiff Deadline in Dexcom Inc. (DXCM) Securities Class Action

September 26, 2024

From Kirby McInerney LLP

Via GlobeNewswire

DexCom Inc. October 21, 2024 Lead Plaintiff Deadline – DXCM Investors Should Contact Robbins LLP for Information

September 26, 2024

From Robbins LLP

Via GlobeNewswire

Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 p.m. Eastern Time.

September 26, 2024

From DexCom, Inc.

Via Business Wire

NASDAQ:DXCM, a strong growth stock, setting up for a breakout. ↗

September 19, 2024

Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.

Via Chartmill

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom

September 25, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

DexCom Is Great. Here's Why You Shouldn't Buy It. ↗

September 25, 2024

Two key uncertainties make the prospect of buying it today riskier than is desirable.

Via The Motley Fool

Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against DexCom, Inc. (DXCM) – Deadline is October 21, 2024

September 24, 2024

From Kaplan Fox & Kilsheimer LLP

Via Business Wire

Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap

September 23, 2024

From DexCom, Inc.

Via Business Wire

DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline

September 23, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm

September 22, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, A RANKED AND LEADING FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

September 21, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom

September 19, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm

September 18, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U

September 18, 2024

From Dexcom, Inc.

Via Business Wire

Kirby McInerney LLP Notifies Dexcom Inc. (DXCM) Investors of Class Action Filing and Encourages Investors to Contact the Firm

September 17, 2024

From Kirby McInerney LLP

Via Business Wire

Uh-Oh! Alphabet Is Selling Its Stake in 2 Historically High-Flying Artificial Intelligence (AI) Stocks ↗

September 17, 2024

These once-sizable artificial intelligence (AI) holdings for Google parent Alphabet have been paired down big-time over the last two quarters.

Via The Motley Fool

Topics Artificial Intelligence

DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline

September 16, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Methode Electronics, DexCom, Endava, and Orthofix and Encourages Investors to Contact the Firm

September 14, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200 ↗

September 14, 2024

No need to break the bank to get in on these excellent companies.

Via The Motley Fool

Faruqi & Faruqi Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM

September 13, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

3 Reasons DexCom Looks Like a No-Brainer Buy Right Now ↗

September 12, 2024

The stock isn't normally this cheap, and investors should take advantage.

Via The Motley Fool

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Methode Electronics, DexCom, Endava, and Orthofix and Encourages Investors to Contact the Firm

September 10, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission

September 10, 2024

From DexCom, Inc.

Via Business Wire

Kirby McInerney LLP Reminds Dexcom Inc. (DXCM) Investors of Class Action Filing and Encourages Investors to Contact the Firm

September 09, 2024

From Kirby McInerney LLP

Via GlobeNewswire

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

47 48 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com